{"id":"NCT00490477","sponsor":"University of Turin, Italy","briefTitle":"The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial","officialTitle":"Polymyxin-B Hemoperfusion Inactivates Circulating Proapoptotic Factors","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2007-07","completion":"2007-12","firstPosted":"2007-06-22","resultsPosted":"2010-06-04","lastUpdate":"2010-06-08"},"enrollment":16,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Gram-Negative Bacterial Infections","Sepsis"],"interventions":[{"type":"DEVICE","name":"Polymyxin -B fiber hemoperfusion system","otherNames":["PMX-B"]}],"arms":[{"label":"CONVENTIONAL","type":"NO_INTERVENTION"},{"label":"POLYMYXIN-B","type":"ACTIVE_COMPARATOR"}],"summary":"Aim of the study is to verify whether Polymyxin-B hemoperfusion protects from renal dysfunction in patients with severe sepsis from gram negative infection.","primaryOutcome":{"measure":"Number of Participants Not Requiring Renal Replacement Therapy (RRT)","timeFrame":"28 days from the admission","effectByArm":[{"arm":"Conventional Treatment (CONV)","deltaMin":3,"sd":null},{"arm":"Polymyxin-B Hemoperfusion Treatment (PMX-B)","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":8},"locations":{"siteCount":1,"countries":["Italy"]},"refs":{"pmids":["18463848"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":8},"commonTop":[]}}